IRINA POLANSKY: Open Payments
NPI 1801866462 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 24 payments from 7 companies in 2025. Trend: 2023 $981 · 2024 $980 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $282 |
| Lilly USA, LLC | 5 | $104 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
Products named: BREZTRI, AIRSUPRA, JARDIANCE, MOUNJARO, FARXIGA, TRINTELLIX, GEMTESA, Ozempic.
Industry payments across IL — which companies pay providers there.
